Air pollution and homocysteine: More evidence that oxidative stress-related genes modify effects of particulate air pollution

Epidemiology

Volumn 21, Issue 2, 2010, Pages 198-206

  Ren, Cizao ^a   Park, Sung Kyun ^b   Vokonas, Pantel S ^c,d   Sparrow, David ^c,d   Wilker, Elissa ^a   Baccarelli, Andrea ^e   Suh, Helen H ^a   Tucker, Katherine L ^f   Wright, Robert O ^a,g   Schwartz, Joel ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MILAN   (Italy)

^f TUFTS UNIVERSITY   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK CARBON; HOMOCYSTEINE;

ADULT; AGED; AIR POLLUTION; ARTICLE; CAUCASIAN; GENE DELETION; GENOTYPE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; UNITED STATES;

AGED; AGED, 80 AND OVER; AIR POLLUTION; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; GENOTYPE; HEART RATE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PARTICULATE MATTER; POLYMORPHISM, SINGLE NUCLEOTIDE; SOOT; VITAMIN B 12; VITAMIN B 6;

EID: 77249107913     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181cc8bfc     Document Type: Article

References (64)

1. Schwartz J, Morris R. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol. 1995;142:23-35.
2. Schwartz J. Air pollution and hospital admissions for heart disease in eight US counties. Epidemiology. 1999;10:17-22.
3. Ren C, Tong S. Health effects of ambient air pollution-recent research development and contemporary methodological challenges. Environ Health. 2008;7:56.
4. Pope CA III, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132-1141.
5. Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard six cities study. Am J Respir Crit Care Med. 2006;173:667-672.
6. Baccarelli A, Martinelli I, Zanobetti A, et al. Exposure to particulate air pollution and risk of deep vein thrombosis. Arch Intern Med. 2008;168: 920-927.
7. Park SK, O'Neill MS, Vokonas PS, et al. Traffic-related particles are associated with elevated homocysteine-the VA Normative Aging Study. Am JRespir Crit Care Med. 2008;178:283-289.
8. Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association. Circulation. 2004;109:2655-2671.
9. Ren C, Baccarelli A, Wilker E, et al. Lipid and endothelial related genes, ambient articulate matter, and heart rate variability-the VA Normative Aging Study. J Epidemiol Community Health. 2010;64:49-56.
10. Ghio AJ, Kim C, Devlin RB. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med. 2000;162:981-988.
11. Gurgueira SA, Lawrence J, Coull B, et al. Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation. Environ Health Perspect. 2002;110:749-755.
12. Kim JY, Mukherjee S, Ngo L, et al. Urinary 8-hydroxy-2'-deoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to fine particulates. Environ Health Perspect. 2004;112:666-671.
13. Vinzents PS, Møller P, Sørensen M, et al. Personal exposure to ultrafine particles and oxidative DNA damage. Environ Health Perspect. 2005; 113:1485-1490.
14. Brook RD. Cardiovascular effects of air pollution. Clin Sci. 2008;115: 175-187.
15. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
16. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl JMed. 1995;332:286-291.
17. van den Berg M, Stehouwer CD, Bierdrager E, Rauwerda JA. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioslcer Thromb Vas Biol. 1996; 16:165-171.
18. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 1997;277:1775-1781.
19. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 1995;346:1395-1398.
20. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia-an effect reversible with vitamin C therapy. Circulation. 1999;99:1156-1160.
21. Stühlinger MC, Oka RK, Graf EE, et al. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation. 2003;108:933-938.
22. Buemi M, Marino D, Pasquale GD, et al. Effects of homocysteine on proliferation, necrosis, and apoptosis of vascular smooth muscle cells in culture and influence of folic acid. Thromb Res. 2001;104:207-213.
23. Gori AM, Corsi AM, Fedi S, et al. A proinflammatory state is associated with hyperhomocysteinenia in the elderly. Am J Clin Nutr. 2005;82:335-341.
24. Evans RW, Shaten BJ, Hempel JD, et al. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol. 1997;17:1947-1953.
25. Park SK, O'Neill MS, Wright RO, et al. HFE genotype, particulate air pollution, and heart rate variability-A gene-environment interaction. Circulation. 2006;114:2798-2805.
26. Schwartz J, Park SK, O'Neill MS, et al. Glutathione-s-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by- environment interaction. Am J Respir Crit Care Med. 2005;172:1529-1533.
27. Chahine T, Baccarelli A, Litonjua A, et al. Particulate air pollution, oxidative stress genes, and heart rate variability in an elderly cohort. Environ Health Perspect. 2007;115:1617-1622.
28. Zeka A, Sullivan JR, Vokonas PS, et al. Inflammatory markers and particulate air pollution: characterizing the pathway to disease. Int J Epidemiol. 2006;35:1347-1354.
29. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-246.
30. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferring receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 1998;95:1472-1477.
31. Bergamaschi E, De Palma G, Mozzoni P, et al. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am J Respir Crit Care Med. 2001;163:1426-1431.
32. Goth L, Vitai M. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocata-lasemic patients. Free Radic Biol Med. 2003;35:882-888.
33. Hayes JD, McLellan LI. Glutathione and glutathione dependent enzymes represent a co-ordinately regulated defense against oxidative stress. Free Radic Res. 1999;31:273-300.
34. Bell B, Rose C, Damon A. The Veterans Administration longitudinal study of healthy aging. Gerontologist. 1966;6:179-184.
35. Tucker KL, Qiao N, Scott T, et al. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82:627-635.
36. Kalkstein L, Valamont K. An evaluation of summer discomfort in the United States using a relative climatologic index. Bull Am Meteorol Soc. 1986;67:842-848.
37. Gilliland FD, YF LI, Saxon A, et al. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomized, placebo-controlled crossover study. Lancet. 2004;363:119-125.
38. Forsberg L, Lyrenäs L, de Faire U, et al. A common functional C-T substitution polymorphisms in the promoter region of the human cata-lase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med. 2001;30:500-505.
39. Rothman N, Smith MT, Hayes RB, et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1609C3 T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 1997;57:2839-2842.
40. Chen YH, Lin SJ, Lin MW, et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetes patients. Hum Genet. 2002; 111:1-8.
41. Kaneda H, Ohno M, Taguchi J, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol. 2002;22:1680-1685.
42. Sun X, Ding H, Hung K, et al. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res. 2000;28:e68.
43. Lee LG, Connell CR Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993;21:3761-3766.
44. de Bree A, Verschuren WM, Blom HJ, et al. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol. 2001;154:150-154. (Pubitemid 32643130)
45. Ganji V, Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2003;77:826-833.
46. Wood SN. Thin plate regression splines. JR Stat Soc B. 2003;65:95-114.
47. Daniels MJ, Dominici F, Samet JM, et al. Estimating particulate matter-mortality dose-response curves and threshold levels: an analysis of daily time-series for the 20 largest US cities. Am J Epidemiol. 2000;152:397-406.
48. Ren C, Williams GM, Tong S. Does particulate matter modify the association between temperature and cardiorespiratory diseases? Environ Health Perspect. 2006;114:1690-1696.
49. Madrigano J, Baccarelli A, Wright RO, et al. Air pollution, obesity, genes and cellular adhesion molecules. Occup Environ Med; DOI: 10.1136/eom.2009.048660 [online: November 2, 2009].
50. Coughlin SS, Hall IJ. Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med. 2002;4:250-257.
51. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
52. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol. 2001;154:193-206.
53. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts /32-microglobulin interaction and cell surfaces expression. J Biol Chem. 1997;272:14025-14028.
54. Quan F, Korneluk RG, Tropak MB, et al. Isolation and characterization of the human catalase gene. Nucleic Acids Res. 1986;14:5321-5335.
55. Mueller S, Riedel HD, Stremmel W. Direct evidence for catalase as the predominant H2O2 removing enzyme in erythrocytes. Blood. 1997;90: 4973-4978.
56. Ahn J, Nowell S, McCann SE, et al. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev. 2006;15:1217-1222.
57. Goth L, Rass P, Pay A. Catalase enzyme mutations and their association with diseases. Mol Diagn. 2004;8:141-149.
58. Capurso C, Solfrizzi V, D'Introno A, et al. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms. Neurosci Lett. 2008;432:237-242.
59. Islam T, McConnell, Gauderman WJ, et al. Ozone, oxidant defense genes, and risk of asthma during adolescence. Am J Respir Crit Care Med. 2008;177:388-395.
60. Mak JC, Leung HC, Ho SP, et al. Polymorphisms in mangases superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy. 2006;36:440-447.
61. Nadif R, Mintz M, Jedlicka A, et al. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res. 2005;39:1345-1350.
62. Ghio AJ, Piantadosi CA, Wang X, et al. Divalent metal transporter-1 decreases metal-related injury in the lung. Am J Physiol Lung Cell Mol Physiol. 2005;289:460-467.
63. Tamagawa E, Bai N, Morimoto K, et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Cell Mol Physiol. 2008;295:79-85.
64. Sarnat JA, Brown KW, Schwartz J, et al. Ambient gas concentrations and personal particulate matter exposures: implications for studying the health effects of particles. Epidemiology. 2005;16:385-395.